A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT06095505 · RECRUITING
Trial details
- NCT number
- NCT06095505
- Sponsor
- Puma Biotechnology, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2027-10-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.